In recent years, this concept has been extended to the field of oncology, and a variety of important proteins, such as the tumor suppressors p53 and PTEN, have been found to be pathologically aggregated in tumors, leading to functional alterations and tumor progression [6–8]. This evidence concerns the gene PTEN and neoplasm.